Patents by Inventor Mark H. Bogart

Mark H. Bogart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6664292
    Abstract: In accordance with the present invention, there are provided methods for treatment of pathological conditions of the nail, said method comprising topically applying to the affected area an effective amount of a composition comprising an optionally substituted lower alcohol and an optionally substituted lower carboxylic acid. Invention methods effectively treat bacterial or fungal infections of the nail by utilizing a low viscosity composition having the ability to penetrate through and underneath the nail plate, thereby attacking the infection at its source.
    Type: Grant
    Filed: June 4, 2001
    Date of Patent: December 16, 2003
    Inventor: Mark H. Bogart
  • Publication number: 20020183387
    Abstract: In accordance with the present invention, there are provided methods for treatment of pathological conditions of the nail, said method comprising topically applying to the affected area an effective amount of a composition comprising an optionally substituted lower alcohol and an optionally substituted lower carboxylic acid. Invention methods effectively treat bacterial or fungal infections of the nail by utilizing a low viscosity composition having the ability to penetrate through and underneath the nail plate, thereby attacking the infection at its source.
    Type: Application
    Filed: June 4, 2001
    Publication date: December 5, 2002
    Inventor: Mark H. Bogart
  • Patent number: 5716776
    Abstract: A method is presented for selective stimulation of fetal lymphocytes to divide in culture after treatment of mixed adult-fetal blood samples. This method is particularly useful for diagnosing genetic abnormalities of a fetus using fetal cells from a maternal blood sample. The method consists of preferential destruction of maternal lymphocyte response to low concentrations of mitotic stimulants which results in a relative increase in the number of responding fetal cells in mixed adult-fetal blood samples. In the preferred embodiment of the invention, blood samples from pregnant women are processed by the described methodology, in particular, the erythrocytes are removed from the maternal sample by centrifugation, filtration or preferential lysis with ammonium bicarbonate, the suspension is then subjected to an osmotic shock and exposed to mitotic stimulants in culture, and cells in mitosis are harvested for chromosome analysis.
    Type: Grant
    Filed: March 4, 1994
    Date of Patent: February 10, 1998
    Assignee: Mark H. Bogart
    Inventor: Mark H. Bogart